CSL Behring

CSL Behring

Corporate Summary

CSL Behring is a plasma collection company, meaning it collects plasma through dozens of facilities in the United States and Germany. The company also develops plasma protein biotherapeutics to treat other disorders, like hemophilia and emphysema.

On December 4, 2007, the Food and Drug Administration (FDA) issued a safety alert for desmopressin, a generic drug used to treat night-time bed-wetting. CSL Behring sells a drug called Stimate Nasal Spray, which is a brand name for the drug. The agency said certain patients are at risk of developing hyponatremia, which is an abnormally low concentration of sodium in the blood that can cause seizures and death.